Treatment of gastrointestinal tumor (GIST) of the rectum requiring abdominoperineal resection following neoadjuvant imatinib: a cost-effectiveness analysis.
Mohamad FaridJohnny OngClaramae ChiaGrace TanMelissa TeoRichard QuekJonathan TehDavid MatcharPublished in: Clinical sarcoma research (2020)
UAPR is more effective and less costly than CIUP for patients with rectal GIST requiring abdominoperineal resection following neoadjuvant imatinib, and is the strategy of choice in this setting.